Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors

Purpose To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study. Setting Twenty-four...

Full description

Saved in:
Bibliographic Details
Published inJournal of cataract and refractive surgery Vol. 33; no. 6; pp. 978 - 988
Main Author ESCRS Endophthalmitis Study Group
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.06.2007
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study. Setting Twenty-four ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal, Spain, Turkey, and the United Kingdom. Methods A prospective randomized partially masked multicenter cataract surgery study recruited 16 603 patients. The study was based on a 2 × 2 factorial design, with intracameral cefuroxime and topical perioperative levofloxacin factors resulting in 4 treatment groups. The comparison of case and non-case data was performed using multivariable logistic regression analyses. Odds ratios (ORs) associated with treatment effects and other risk factors were estimated. Results Twenty-nine patients presented with endophthalmitis, of whom 20 were classified as having proven infective endophthalmitis. The absence of an intracameral cefuroxime prophylactic regimen at 1 mg in 0.1 mL normal saline was associated with a 4.92-fold increase (95% confidence interval [CI], 1.87-12.9) in the risk for total postoperative endophthalmitis. In addition, the use of clear corneal incisions (CCIs) compared to scleral tunnels was associated with a 5.88-fold increase (95% CI, 1.34-25.9) in risk and the use of silicone intraocular lens (IOL) optic material compared to acrylic with a 3.13-fold increase (95% CI, 1.47-6.67). The presence of surgical complications increased the risk for total endophthalmitis 4.95-fold (95% CI, 1.68-14.6), and more experienced surgeons were more likely to be associated with endophthalmitis cases. When considering only proven infective endophthalmitis cases, the absence of cefuroxime and the use of silicone IOL optic material were significantly associated with an increased risk, and there was evidence that men were more predisposed to infection (OR, 2.70; 95% CI, 1.07-6.8). Conclusions Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis. Additional risk factors associated with endophthalmitis after cataract surgery included CCIs and the use of silicone IOLs.
AbstractList To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study. Twenty-four ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal, Spain, Turkey, and the United Kingdom. A prospective randomized partially masked multicenter cataract surgery study recruited 16 603 patients. The study was based on a 2 x 2 factorial design, with intracameral cefuroxime and topical perioperative levofloxacin factors resulting in 4 treatment groups. The comparison of case and non-case data was performed using multivariable logistic regression analyses. Odds ratios (ORs) associated with treatment effects and other risk factors were estimated. Twenty-nine patients presented with endophthalmitis, of whom 20 were classified as having proven infective endophthalmitis. The absence of an intracameral cefuroxime prophylactic regimen at 1 mg in 0.1 mL normal saline was associated with a 4.92-fold increase (95% confidence interval [CI], 1.87-12.9) in the risk for total postoperative endophthalmitis. In addition, the use of clear corneal incisions (CCIs) compared to scleral tunnels was associated with a 5.88-fold increase (95% CI, 1.34-25.9) in risk and the use of silicone intraocular lens (IOL) optic material compared to acrylic with a 3.13-fold increase (95% CI, 1.47-6.67). The presence of surgical complications increased the risk for total endophthalmitis 4.95-fold (95% CI, 1.68-14.6), and more experienced surgeons were more likely to be associated with endophthalmitis cases. When considering only proven infective endophthalmitis cases, the absence of cefuroxime and the use of silicone IOL optic material were significantly associated with an increased risk, and there was evidence that men were more predisposed to infection (OR, 2.70; 95% CI, 1.07-6.8). Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis. Additional risk factors associated with endophthalmitis after cataract surgery included CCIs and the use of silicone IOLs.
PURPOSETo identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study.SETTINGTwenty-four ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal, Spain, Turkey, and the United Kingdom.METHODSA prospective randomized partially masked multicenter cataract surgery study recruited 16 603 patients. The study was based on a 2 x 2 factorial design, with intracameral cefuroxime and topical perioperative levofloxacin factors resulting in 4 treatment groups. The comparison of case and non-case data was performed using multivariable logistic regression analyses. Odds ratios (ORs) associated with treatment effects and other risk factors were estimated.RESULTSTwenty-nine patients presented with endophthalmitis, of whom 20 were classified as having proven infective endophthalmitis. The absence of an intracameral cefuroxime prophylactic regimen at 1 mg in 0.1 mL normal saline was associated with a 4.92-fold increase (95% confidence interval [CI], 1.87-12.9) in the risk for total postoperative endophthalmitis. In addition, the use of clear corneal incisions (CCIs) compared to scleral tunnels was associated with a 5.88-fold increase (95% CI, 1.34-25.9) in risk and the use of silicone intraocular lens (IOL) optic material compared to acrylic with a 3.13-fold increase (95% CI, 1.47-6.67). The presence of surgical complications increased the risk for total endophthalmitis 4.95-fold (95% CI, 1.68-14.6), and more experienced surgeons were more likely to be associated with endophthalmitis cases. When considering only proven infective endophthalmitis cases, the absence of cefuroxime and the use of silicone IOL optic material were significantly associated with an increased risk, and there was evidence that men were more predisposed to infection (OR, 2.70; 95% CI, 1.07-6.8).CONCLUSIONSUse of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis. Additional risk factors associated with endophthalmitis after cataract surgery included CCIs and the use of silicone IOLs.
To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study. Twenty-four ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal, Spain, Turkey, and the United Kingdom. A prospective randomized partially masked multicenter cataract surgery study recruited 16 603 patients. The study was based on a 2 × 2 factorial design, with intracameral cefuroxime and topical perioperative levofloxacin factors resulting in 4 treatment groups. The comparison of case and non-case data was performed using multivariable logistic regression analyses. Odds ratios (ORs) associated with treatment effects and other risk factors were estimated. Twenty-nine patients presented with endophthalmitis, of whom 20 were classified as having proven infective endophthalmitis. The absence of an intracameral cefuroxime prophylactic regimen at 1 mg in 0.1 mL normal saline was associated with a 4.92-fold increase (95% confidence interval [CI], 1.87-12.9) in the risk for total postoperative endophthalmitis. In addition, the use of clear corneal incisions (CCIs) compared to scleral tunnels was associated with a 5.88-fold increase (95% CI, 1.34-25.9) in risk and the use of silicone intraocular lens (IOL) optic material compared to acrylic with a 3.13-fold increase (95% CI, 1.47-6.67). The presence of surgical complications increased the risk for total endophthalmitis 4.95-fold (95% CI, 1.68-14.6), and more experienced surgeons were more likely to be associated with endophthalmitis cases. When considering only proven infective endophthalmitis cases, the absence of cefuroxime and the use of silicone IOL optic material were significantly associated with an increased risk, and there was evidence that men were more predisposed to infection (OR, 2.70; 95% CI, 1.07-6.8). Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis. Additional risk factors associated with endophthalmitis after cataract surgery included CCIs and the use of silicone IOLs.
Purpose To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study. Setting Twenty-four ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal, Spain, Turkey, and the United Kingdom. Methods A prospective randomized partially masked multicenter cataract surgery study recruited 16 603 patients. The study was based on a 2 × 2 factorial design, with intracameral cefuroxime and topical perioperative levofloxacin factors resulting in 4 treatment groups. The comparison of case and non-case data was performed using multivariable logistic regression analyses. Odds ratios (ORs) associated with treatment effects and other risk factors were estimated. Results Twenty-nine patients presented with endophthalmitis, of whom 20 were classified as having proven infective endophthalmitis. The absence of an intracameral cefuroxime prophylactic regimen at 1 mg in 0.1 mL normal saline was associated with a 4.92-fold increase (95% confidence interval [CI], 1.87-12.9) in the risk for total postoperative endophthalmitis. In addition, the use of clear corneal incisions (CCIs) compared to scleral tunnels was associated with a 5.88-fold increase (95% CI, 1.34-25.9) in risk and the use of silicone intraocular lens (IOL) optic material compared to acrylic with a 3.13-fold increase (95% CI, 1.47-6.67). The presence of surgical complications increased the risk for total endophthalmitis 4.95-fold (95% CI, 1.68-14.6), and more experienced surgeons were more likely to be associated with endophthalmitis cases. When considering only proven infective endophthalmitis cases, the absence of cefuroxime and the use of silicone IOL optic material were significantly associated with an increased risk, and there was evidence that men were more predisposed to infection (OR, 2.70; 95% CI, 1.07-6.8). Conclusions Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis. Additional risk factors associated with endophthalmitis after cataract surgery included CCIs and the use of silicone IOLs.
Author ESCRS Endophthalmitis Study Group
AuthorAffiliation European Society of Cataract & Refractive Surgeons, Dublin, Ireland. escrs@agenda.com
AuthorAffiliation_xml – name: European Society of Cataract & Refractive Surgeons, Dublin, Ireland. escrs@agenda.com
Author_xml – sequence: 1
  fullname: ESCRS Endophthalmitis Study Group
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18837796$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17531690$$D View this record in MEDLINE/PubMed
BookMark eNp9kl-LEzEUxYOsuN3VL-CD5EXfWjOTyWRGRJCy_oEFZavPIU3ubNNNk5qbWe3X8BObsYUFH3wK3PzO4XLOvSBnIQYg5HnFFhWr2tfbxdYkXNSMyQWrF4zXj8is6iSfN4LVZ2TGuq6dcy7YOblA3DLGmpqLJ-S8koJXbc9m5PfXFPebg9e_HNI40H3EHPeQdHb3QCHY8ps32u9cLsAQvY8_XbilRmedtMkUx3QL6fCG3gCOPv81yRugV6vlzYruysgZCBkSxTzaA9XBUmfLxA2umLgYJkVyeEeH4hcTPiWPB-0Rnp3eS_L9w9W35af59ZePn5fvr-dGNH2eSz70VgAM0kro-sYK2bYAtekrWHc9Xxthe93KddMwxju-Bq573tbcNKwBWfNL8urou0_xxwiY1c6hAe91gDiikkwIUUlewPoImhQREwxqn9xOp4OqmJqaUFs1NaGmJhSrVWmiiF6c3Mf1DuyD5BR9AV6eAI1G-yHpYBw-cF3Hpezbwr09clCyuHeQFBoHwYB1CUxWNrr_7_HuH7nxLpTo_R0cALdxTKGkrCqFRaBW081MJ8NkuZaW9fwPQMbBfQ
CODEN JCSUEV
CitedBy_id crossref_primary_10_1016_j_jcrs_2008_01_001
crossref_primary_10_1186_s12886_021_02175_z
crossref_primary_10_1111_ceo_12932
crossref_primary_10_1099_jmm_0_026609_0
crossref_primary_10_1016_j_ophtha_2016_02_040
crossref_primary_10_1016_j_ophtha_2017_11_018
crossref_primary_10_1038_eye_2015_271
crossref_primary_10_1097_ICU_0000000000000115
crossref_primary_10_1016_j_jcrs_2012_03_024
crossref_primary_10_1177_11206721221145055
crossref_primary_10_1016_j_jcrs_2011_01_019
crossref_primary_10_1016_j_jcrs_2013_05_036
crossref_primary_10_1097_ICU_0b013e3283414fb3
crossref_primary_10_1007_s12325_016_0307_8
crossref_primary_10_1016_j_jcrs_2015_01_014
crossref_primary_10_1007_s00417_019_04417_9
crossref_primary_10_1055_a_1758_3451
crossref_primary_10_1016_S0140_6736_17_30544_5
crossref_primary_10_1097_IAE_0000000000001052
crossref_primary_10_1016_j_oret_2020_09_010
crossref_primary_10_1016_j_ejpb_2017_08_006
crossref_primary_10_1097_APO_0b013e31823e574b
crossref_primary_10_7759_cureus_42662
crossref_primary_10_1155_2023_3132866
crossref_primary_10_1016_j_jcrs_2018_07_055
crossref_primary_10_3109_09273948_2015_1075559
crossref_primary_10_4103_2320_3897_183726
crossref_primary_10_1016_j_biomaterials_2012_07_052
crossref_primary_10_1111_j_1444_0938_2010_00516_x
crossref_primary_10_1186_s40942_021_00280_1
crossref_primary_10_1136_bcr_2021_247772
crossref_primary_10_1007_s40123_021_00435_1
crossref_primary_10_3346_jkms_2018_33_e180
crossref_primary_10_1016_j_ajo_2012_06_024
crossref_primary_10_1016_j_jcrs_2011_08_038
crossref_primary_10_1016_j_ijpharm_2010_07_009
crossref_primary_10_1016_j_oftale_2014_01_007
crossref_primary_10_1097_IAE_0b013e31819d2591
crossref_primary_10_1080_02713683_2016_1256414
crossref_primary_10_1089_jop_2016_0019
crossref_primary_10_1016_j_jcrs_2007_07_009
crossref_primary_10_1016_j_jcrs_2016_11_048
crossref_primary_10_2146_ajhp120568
crossref_primary_10_4236_ojoph_2015_52008
crossref_primary_10_1111_j_1442_9071_2008_01869_x
crossref_primary_10_4103_ejos_ejos_85_23
crossref_primary_10_1080_02713680802382971
crossref_primary_10_1155_2018_8567912
crossref_primary_10_3109_03639045_2015_1038273
crossref_primary_10_1016_j_jfo_2014_11_005
crossref_primary_10_1080_17469899_2017_1318065
crossref_primary_10_1155_2015_813697
crossref_primary_10_1186_1471_2415_12_2
crossref_primary_10_1016_S1283_0771_20_43269_4
crossref_primary_10_3390_biomedicines10081920
crossref_primary_10_1016_j_ajo_2016_06_012
crossref_primary_10_1097_j_jcrs_0000000000001151
crossref_primary_10_1097_ICU_0b013e32835b0716
crossref_primary_10_1007_s40123_023_00835_5
crossref_primary_10_1016_j_jcro_2016_10_004
crossref_primary_10_1097_IPC_0b013e318184d77a
crossref_primary_10_3109_08820530903389692
crossref_primary_10_1111_aos_15732
crossref_primary_10_1016_j_ajo_2018_01_030
crossref_primary_10_1111_aos_13314
crossref_primary_10_1016_j_jcrs_2009_05_061
crossref_primary_10_1016_j_ophtha_2016_08_035
crossref_primary_10_1016_j_ajo_2018_03_042
crossref_primary_10_1016_j_jhin_2011_02_004
crossref_primary_10_1111_j_1755_3768_2008_01358_x
crossref_primary_10_1016_j_jcrs_2009_02_001
crossref_primary_10_1016_j_jfo_2011_05_002
crossref_primary_10_1038_s41433_019_0758_7
crossref_primary_10_1016_j_ajo_2021_02_007
crossref_primary_10_1111_ceo_12847
crossref_primary_10_3390_jcm10051059
crossref_primary_10_1016_j_jcrs_2016_02_026
crossref_primary_10_1177_11206721221124673
crossref_primary_10_1016_j_jcrs_2016_09_013
crossref_primary_10_1016_j_jcrs_2009_03_049
crossref_primary_10_1371_journal_pone_0156856
crossref_primary_10_1136_bcr_2021_246985
crossref_primary_10_1016_j_jfo_2011_05_007
crossref_primary_10_1111_aos_12221
crossref_primary_10_1038_eye_2008_173
crossref_primary_10_1038_eye_2008_295
crossref_primary_10_1007_s10792_022_02508_x
crossref_primary_10_1097_APO_0b013e31826cd8f2
crossref_primary_10_1371_journal_pone_0110872
crossref_primary_10_1038_eye_2012_40
crossref_primary_10_3390_pharmaceutics12060572
crossref_primary_10_1007_s40135_018_0171_6
crossref_primary_10_1016_S2173_5794_10_70051_7
crossref_primary_10_1016_j_jcrs_2008_02_013
crossref_primary_10_1016_j_ajic_2013_01_042
crossref_primary_10_1038_s41598_022_21423_w
crossref_primary_10_2147_IDR_S252674
crossref_primary_10_1080_15569527_2020_1813748
crossref_primary_10_1016_S0929_693X_13_71412_X
crossref_primary_10_1586_17469899_3_1_17
crossref_primary_10_1155_2019_5746186
crossref_primary_10_1111_j_1442_9071_2010_02402_x
crossref_primary_10_1016_j_jcrs_2014_07_011
crossref_primary_10_1080_17469899_2021_1962296
crossref_primary_10_1007_s10384_009_0718_z
crossref_primary_10_1080_02713683_2019_1701686
crossref_primary_10_1016_j_jcrs_2016_11_007
crossref_primary_10_1016_S1283_0771_10_70260_7
crossref_primary_10_1155_2021_5526097
crossref_primary_10_3928_01913913_20170823_02
crossref_primary_10_3109_02713683_2012_763101
crossref_primary_10_1016_j_jhin_2013_05_009
crossref_primary_10_1089_jop_2012_0062
crossref_primary_10_1111_aos_12684
crossref_primary_10_1007_s10792_016_0279_3
crossref_primary_10_1016_j_jfo_2022_12_028
crossref_primary_10_1016_j_jcrs_2016_12_025
crossref_primary_10_7759_cureus_53532
crossref_primary_10_1111_ceo_12524
crossref_primary_10_1111_ceo_13737
crossref_primary_10_1016_j_ajo_2023_11_003
crossref_primary_10_1097_IAE_0000000000003570
crossref_primary_10_1016_j_ophtha_2016_02_019
crossref_primary_10_1097_IAE_0b013e3182947b29
crossref_primary_10_1007_s00417_015_3009_z
crossref_primary_10_4137_OED_S4866
crossref_primary_10_1038_s41433_020_0869_1
crossref_primary_10_18410_jebmh_2021_495
crossref_primary_10_3238_arztebl_2009_0695
crossref_primary_10_1016_j_mexoft_2014_09_007
crossref_primary_10_1007_s10792_014_0017_7
crossref_primary_10_1186_1471_2415_14_57
crossref_primary_10_1007_s10792_016_0307_3
crossref_primary_10_1016_j_jfo_2013_06_007
crossref_primary_10_1016_j_mexoft_2014_09_004
crossref_primary_10_1016_j_jcrs_2008_04_058
crossref_primary_10_17925_USOR_2018_11_1_15
crossref_primary_10_1016_j_oftale_2014_06_004
crossref_primary_10_1016_j_jcrs_2013_11_023
crossref_primary_10_1016_j_oftale_2020_12_011
crossref_primary_10_1016_j_jcrs_2014_05_033
crossref_primary_10_17816_OV10162_69
crossref_primary_10_1007_s40123_021_00406_6
crossref_primary_10_1016_j_farma_2011_07_003
crossref_primary_10_1016_j_jcrs_2014_05_038
crossref_primary_10_1097_ICO_0b013e318191447b
crossref_primary_10_5005_hoo_10101_41605
crossref_primary_10_1111_j_1755_3768_2011_02324_x
crossref_primary_10_1016_j_yaoo_2018_05_005
crossref_primary_10_1038_s41433_020_01303_1
crossref_primary_10_1186_1471_2415_13_71
crossref_primary_10_4103_ojo_OJO_249_2020
crossref_primary_10_1016_j_ophtha_2012_07_013
crossref_primary_10_4265_bio_15_97
crossref_primary_10_1007_s00347_007_1624_8
crossref_primary_10_1007_s00347_014_3032_1
crossref_primary_10_1136_ejhpharm_2013_000307
crossref_primary_10_1159_000441662
crossref_primary_10_1016_j_ijpharm_2021_121185
crossref_primary_10_1089_jop_2008_0102
crossref_primary_10_1016_j_jcrs_2008_03_017
crossref_primary_10_1002_pds_4149
crossref_primary_10_1016_j_ophtha_2016_03_024
crossref_primary_10_1016_j_oret_2022_03_009
crossref_primary_10_1016_j_ophtha_2016_04_039
crossref_primary_10_1007_s10156_009_0687_7
crossref_primary_10_1111_j_1755_3768_2008_01441_x
crossref_primary_10_1111_vop_13023
crossref_primary_10_1016_S0246_0343_08_44080_7
crossref_primary_10_1016_j_survophthal_2020_10_006
crossref_primary_10_1186_s12886_019_1028_y
crossref_primary_10_1016_j_ophtha_2021_10_006
crossref_primary_10_5301_ejo_5000473
crossref_primary_10_1097_IAE_0000000000001583
crossref_primary_10_1016_j_jcrs_2009_05_039
crossref_primary_10_1016_j_jcrs_2013_11_046
crossref_primary_10_1155_2017_1261698
crossref_primary_10_1016_j_ophtha_2014_03_032
crossref_primary_10_1016_j_ajo_2016_04_013
crossref_primary_10_1016_j_jcrs_2008_03_021
crossref_primary_10_1111_aos_14018
crossref_primary_10_1016_j_jcrs_2019_03_027
crossref_primary_10_1007_s40135_018_0174_3
crossref_primary_10_3390_antibiotics12081246
crossref_primary_10_1016_j_jcro_2014_05_002
crossref_primary_10_4137_OED_S13102
crossref_primary_10_1007_s15010_008_8150_8
crossref_primary_10_1177_0018578718757516
crossref_primary_10_1016_j_jcrs_2018_10_044
crossref_primary_10_3390_bioengineering7030065
crossref_primary_10_1016_j_jcrs_2015_11_010
crossref_primary_10_1007_s40123_023_00661_9
crossref_primary_10_1586_17469899_2_2_213
crossref_primary_10_1016_j_jcrs_2007_10_041
crossref_primary_10_1016_j_jcrs_2011_07_013
crossref_primary_10_1016_j_jhin_2011_07_009
crossref_primary_10_1016_j_jcrs_2014_06_042
crossref_primary_10_1080_17469899_2019_1674140
crossref_primary_10_3928_23258160_20221026_03
crossref_primary_10_1016_j_jcrs_2009_12_013
crossref_primary_10_1016_j_jcrs_2010_08_047
crossref_primary_10_1080_17469899_2017_1302798
crossref_primary_10_1586_17469899_2015_1088782
crossref_primary_10_1002_14651858_CD013270_pub2
crossref_primary_10_1136_bjophthalmol_2013_304485
crossref_primary_10_12677_acm_2024_1441170
crossref_primary_10_1038_eye_2010_39
crossref_primary_10_12968_ijop_2014_5_5_167
crossref_primary_10_1007_s40135_013_0020_6
crossref_primary_10_1007_s15010_011_0138_0
crossref_primary_10_1007_s00347_013_2904_0
crossref_primary_10_1016_S0084_392X_08_79175_5
crossref_primary_10_1007_s00347_010_2219_3
crossref_primary_10_5005_hov_10102_06201
crossref_primary_10_1016_j_oftal_2010_11_005
crossref_primary_10_1016_j_jcrs_2014_10_010
crossref_primary_10_1016_j_ophtha_2016_11_042
crossref_primary_10_3389_fcimb_2023_1172345
crossref_primary_10_1016_j_ajoc_2020_100903
crossref_primary_10_1155_2020_7242969
crossref_primary_10_1016_j_ajoc_2020_100905
crossref_primary_10_1016_j_jcrs_2015_06_031
crossref_primary_10_1016_j_jcrs_2010_08_051
crossref_primary_10_1093_jac_dkr009
crossref_primary_10_3129_i08_133
crossref_primary_10_12968_ijop_2012_3_1_4
crossref_primary_10_1016_j_jcrs_2008_05_043
crossref_primary_10_1055_s_0043_1771043
crossref_primary_10_1016_S0084_392X_10_79348_5
crossref_primary_10_1016_j_jcrs_2012_09_004
crossref_primary_10_1016_j_jcrs_2008_05_045
crossref_primary_10_3928_23258160_20180501_12
crossref_primary_10_5005_hos_10101_41501
crossref_primary_10_1097_APO_0b013e31823e4c1e
crossref_primary_10_3390_toxins11060356
crossref_primary_10_1111_ceo_12910
crossref_primary_10_5005_hoo_10101_41501
crossref_primary_10_2147_IDR_S304675
crossref_primary_10_1080_17469899_2023_2264508
crossref_primary_10_1016_j_ophtha_2011_11_023
crossref_primary_10_1007_s10792_021_02142_z
crossref_primary_10_4236_ojoph_2020_101004
crossref_primary_10_1007_s10792_015_0151_x
crossref_primary_10_1016_j_ajo_2010_04_010
crossref_primary_10_1080_09273948_2022_2152699
crossref_primary_10_3341_jkos_2015_56_12_1854
crossref_primary_10_1177_112067210901900407
crossref_primary_10_3129_i08_144
crossref_primary_10_1016_j_jcrs_2019_04_018
crossref_primary_10_1016_j_jcrs_2014_05_050
crossref_primary_10_1016_j_preteyeres_2012_03_004
crossref_primary_10_1007_s40135_013_0021_5
crossref_primary_10_1007_s00417_018_3954_4
crossref_primary_10_1111_aos_12279
crossref_primary_10_1016_j_jcrs_2009_06_038
crossref_primary_10_1016_j_jcrs_2011_09_040
crossref_primary_10_1007_s10792_020_01457_7
crossref_primary_10_1016_j_ajo_2016_11_006
crossref_primary_10_1016_j_ophtha_2012_07_031
crossref_primary_10_1016_j_jcrs_2008_10_018
crossref_primary_10_1016_j_jcrs_2009_06_037
crossref_primary_10_1136_bcr_2020_239799
crossref_primary_10_1007_s40135_019_00224_x
crossref_primary_10_1097_ICU_0000000000000907
crossref_primary_10_1111_aos_13121
crossref_primary_10_2147_OPTH_S458130
crossref_primary_10_1007_s10792_021_01967_y
crossref_primary_10_1097_MD_0000000000008941
crossref_primary_10_1016_j_jfo_2009_11_010
crossref_primary_10_1111_aos_12827
crossref_primary_10_1089_jop_2014_0029
crossref_primary_10_1080_08820538_2017_1353826
crossref_primary_10_1016_j_ophtha_2015_03_016
crossref_primary_10_1016_j_jcrs_2015_04_006
crossref_primary_10_1155_2021_9985821
crossref_primary_10_1038_eye_2009_218
crossref_primary_10_1155_2011_982410
crossref_primary_10_1016_j_survophthal_2020_04_006
crossref_primary_10_1007_s00347_018_0729_6
crossref_primary_10_1586_eop_12_77
crossref_primary_10_1016_j_jcrs_2014_11_010
crossref_primary_10_1097_IAE_0000000000000513
crossref_primary_10_1097_IAE_0000000000001603
crossref_primary_10_1016_j_ajoc_2018_12_003
crossref_primary_10_5301_ejo_5000738
crossref_primary_10_1016_j_ajo_2013_04_025
crossref_primary_10_1016_j_jcrs_2010_12_050
crossref_primary_10_1016_j_ophtha_2015_03_003
crossref_primary_10_1016_j_ajo_2013_04_024
crossref_primary_10_1007_s00417_009_1085_7
crossref_primary_10_1016_j_jcrs_2010_03_008
crossref_primary_10_1186_s12886_015_0056_5
crossref_primary_10_3341_kjo_2015_29_1_7
crossref_primary_10_1016_j_jcrs_2016_07_022
crossref_primary_10_1097_j_jcrs_0000000000000757
crossref_primary_10_1055_a_1814_6033
crossref_primary_10_1097_j_jcrs_0000000000000516
crossref_primary_10_1177_1120672117747043
crossref_primary_10_1186_s12348_016_0115_y
crossref_primary_10_1016_j_jcrs_2010_12_046
crossref_primary_10_1157_13128276
crossref_primary_10_1007_s00717_008_0239_z
crossref_primary_10_1007_s00717_017_0350_0
crossref_primary_10_1038_eye_2017_85
crossref_primary_10_1016_j_jfo_2012_10_001
crossref_primary_10_1097_APO_0000000000000014
crossref_primary_10_4103_IJO_IJO_702_23
crossref_primary_10_1016_j_jcrs_2008_05_034
crossref_primary_10_1016_j_oftal_2020_12_018
crossref_primary_10_1016_j_jcrs_2007_12_025
crossref_primary_10_5301_ejo_5000642
crossref_primary_10_1016_j_jcrs_2012_07_038
crossref_primary_10_1002_14651858_CD006364_pub3
crossref_primary_10_1016_S1280_4703_20_43649_7
crossref_primary_10_1016_j_jcrs_2014_04_040
crossref_primary_10_1002_jcph_2451
crossref_primary_10_1016_j_jfo_2010_07_011
crossref_primary_10_1136_bmjophth_2020_000464
crossref_primary_10_1097_ICU_0b013e32834cd5a9
crossref_primary_10_3390_ijerph16122188
crossref_primary_10_1097_ICO_0000000000000441
crossref_primary_10_1586_17469899_2_5_803
crossref_primary_10_2147_OPTH_S459266
crossref_primary_10_1016_j_jcrs_2010_03_013
crossref_primary_10_1016_j_jcrs_2015_05_029
crossref_primary_10_1016_j_jcrs_2017_08_009
crossref_primary_10_1016_j_ophtha_2013_08_046
crossref_primary_10_1016_j_jfo_2009_04_026
crossref_primary_10_1016_S0008_4182_08_80002_6
crossref_primary_10_1016_j_jcrs_2012_07_031
crossref_primary_10_1007_s10096_010_0901_7
crossref_primary_10_1016_j_ophtha_2015_12_011
crossref_primary_10_1089_jop_2022_0144
crossref_primary_10_1016_j_jcrs_2009_08_034
crossref_primary_10_1016_j_jcrs_2010_04_030
crossref_primary_10_1016_j_ijpharm_2018_12_028
crossref_primary_10_4265_bio_17_93
crossref_primary_10_1007_s10792_018_0825_2
crossref_primary_10_1016_S0181_5512_07_79285_9
crossref_primary_10_1007_s00347_009_2027_9
crossref_primary_10_1097_APO_0000000000000151
crossref_primary_10_17116_oftalma2020136042258
crossref_primary_10_1177_11206721231200996
crossref_primary_10_1016_j_ophtha_2021_09_004
crossref_primary_10_1016_j_ajo_2016_02_001
crossref_primary_10_1038_s41598_023_45398_4
crossref_primary_10_3109_15569527_2014_918138
crossref_primary_10_1016_j_jcrs_2008_12_027
crossref_primary_10_1177_20420986241258049
crossref_primary_10_3390_microorganisms12040649
crossref_primary_10_1016_j_jcrs_2008_12_023
crossref_primary_10_1016_j_jcrs_2011_06_036
crossref_primary_10_1586_17469899_2014_951331
crossref_primary_10_1167_tvst_10_3_1
crossref_primary_10_1016_j_ajo_2016_08_024
crossref_primary_10_1016_j_oret_2019_03_009
crossref_primary_10_1016_j_oftal_2020_04_005
crossref_primary_10_1016_j_oftale_2016_07_003
crossref_primary_10_1155_2022_4857696
crossref_primary_10_5812_jjm_13108
crossref_primary_10_1097_ICU_0000000000000727
crossref_primary_10_1007_s11845_014_1127_y
crossref_primary_10_1111_ceo_12199
crossref_primary_10_1016_j_jcrs_2014_02_006
crossref_primary_10_1016_j_ogla_2018_05_001
crossref_primary_10_1016_j_sapharm_2016_05_093
crossref_primary_10_7717_peerj_12305
crossref_primary_10_1016_j_jcrs_2010_10_007
crossref_primary_10_1016_j_jcrs_2007_11_027
crossref_primary_10_1097_j_jcrs_0000000000000559
crossref_primary_10_1016_j_survophthal_2017_04_004
crossref_primary_10_1007_s00417_014_2658_7
crossref_primary_10_1016_j_jcrs_2017_07_028
crossref_primary_10_1055_a_1488_0918
crossref_primary_10_1097_IAE_0000000000000727
crossref_primary_10_1097_j_jcrs_0000000000000672
crossref_primary_10_1016_S0246_0343_08_49001_9
crossref_primary_10_1016_j_jcrs_2009_08_023
crossref_primary_10_1556_650_2021_31941
crossref_primary_10_5301_ejo_5000964
crossref_primary_10_1016_j_oftal_2016_03_009
crossref_primary_10_1016_j_jfo_2016_11_006
crossref_primary_10_1097_APO_0b013e31823ff9de
crossref_primary_10_1016_j_jcrs_2016_06_030
crossref_primary_10_1016_j_oftale_2015_06_006
crossref_primary_10_1111_1469_0691_12118
crossref_primary_10_1186_s12886_023_03003_2
crossref_primary_10_1016_j_jcrs_2011_06_018
crossref_primary_10_1111_aos_14175
crossref_primary_10_1097_ICU_0000000000000625
crossref_primary_10_1111_j_1442_9071_2010_02279_x
crossref_primary_10_1016_j_jcrs_2019_06_009
crossref_primary_10_1038_s41433_021_01548_4
crossref_primary_10_1016_j_jcrs_2009_01_002
crossref_primary_10_22608_APO_201866
crossref_primary_10_1016_j_jcrs_2009_01_003
crossref_primary_10_1111_aos_12668
crossref_primary_10_1016_j_joco_2016_05_002
crossref_primary_10_1016_j_ophtha_2015_09_037
crossref_primary_10_1038_nrdp_2015_14
crossref_primary_10_1097_ICU_0b013e32835a93be
crossref_primary_10_22608_APO_2017343
crossref_primary_10_1016_j_ajo_2015_09_028
crossref_primary_10_1007_s40123_018_0138_6
crossref_primary_10_3341_jkos_2017_58_6_663
crossref_primary_10_1001_jamaophthalmol_2024_1716
crossref_primary_10_1038_s41598_018_25030_6
crossref_primary_10_1097_j_jcrs_0000000000001305
crossref_primary_10_1016_j_oftal_2013_10_008
crossref_primary_10_1016_j_jcrs_2013_06_008
crossref_primary_10_1097_IIO_0000000000000327
crossref_primary_10_1097_j_jcrs_0000000000000697
crossref_primary_10_1111_ceo_13739
crossref_primary_10_1016_j_jcro_2018_08_001
crossref_primary_10_1016_j_ogla_2020_07_008
crossref_primary_10_1136_bjophthalmol_2014_306586
crossref_primary_10_1186_s12886_020_01615_6
crossref_primary_10_3341_kjo_2022_0014
crossref_primary_10_1111_ceo_13991
crossref_primary_10_1016_j_jcrs_2012_12_001
crossref_primary_10_1111_ceo_12789
crossref_primary_10_1002_cbdv_202301382
crossref_primary_10_1016_j_ajo_2013_05_018
crossref_primary_10_1097_IAE_0b013e3181953a31
crossref_primary_10_1016_j_ajo_2013_10_018
crossref_primary_10_1186_s40942_015_0010_y
crossref_primary_10_2165_00003495_200969090_00009
crossref_primary_10_7759_cureus_19469
crossref_primary_10_1016_j_jcrs_2018_05_022
crossref_primary_10_1016_j_jcrs_2012_05_024
crossref_primary_10_1097_j_jcrs_0000000000000563
crossref_primary_10_2147_OPTH_S422502
crossref_primary_10_1016_j_vhri_2020_01_007
crossref_primary_10_1155_2015_912481
crossref_primary_10_1016_j_jcrs_2018_12_019
crossref_primary_10_1136_bmjophth_2020_000635
crossref_primary_10_1097_APO_0000000000000415
crossref_primary_10_1038_s41598_020_71050_6
crossref_primary_10_1590_S0080_62342012000300010
crossref_primary_10_22608_APO_2017200
crossref_primary_10_1007_s40265_013_0011_9
crossref_primary_10_1016_j_preteyeres_2016_04_007
crossref_primary_10_1089_sur_2013_9999
crossref_primary_10_1016_j_oret_2020_11_015
crossref_primary_10_1016_j_oftal_2010_07_006
crossref_primary_10_1007_s10384_017_0545_6
crossref_primary_10_1097_j_jcrs_0000000000000599
crossref_primary_10_1016_j_oftal_2013_06_007
crossref_primary_10_5005_highlights_44_1_11
crossref_primary_10_1016_j_jcrs_2010_01_030
crossref_primary_10_1097_ICB_0000000000000725
crossref_primary_10_1016_j_jcrs_2019_07_022
crossref_primary_10_1016_j_ophtha_2017_01_026
crossref_primary_10_1007_s10792_021_01830_0
crossref_primary_10_1111_ceo_13890
crossref_primary_10_1371_journal_pone_0189778
crossref_primary_10_1016_j_ajo_2010_08_044
crossref_primary_10_1016_S0246_0289_10_44761_1
crossref_primary_10_2144_fsoa_2022_0076
crossref_primary_10_1016_S0716_8640_10_70615_5
crossref_primary_10_1177_1120672120963458
crossref_primary_10_1007_s00417_013_2294_7
crossref_primary_10_1016_j_jcrs_2013_06_014
crossref_primary_10_1097_IIO_0000000000000122
crossref_primary_10_1155_2016_9186351
crossref_primary_10_1136_bmjopen_2018_027036
crossref_primary_10_1016_j_jcrs_2019_07_016
crossref_primary_10_1038_s41433_021_01886_3
crossref_primary_10_1007_s00417_015_3188_7
crossref_primary_10_1016_j_jcrs_2011_03_032
crossref_primary_10_1016_j_jcrs_2014_08_027
crossref_primary_10_1016_j_oftale_2020_04_019
crossref_primary_10_1007_s10792_023_02816_w
crossref_primary_10_1097_01_APO_0000617904_11979_ae
crossref_primary_10_1007_s00417_017_3686_x
crossref_primary_10_1007_s00417_021_05084_5
crossref_primary_10_2147_IDR_S332997
crossref_primary_10_1016_j_ophtha_2017_01_038
crossref_primary_10_5402_2011_917265
crossref_primary_10_1016_j_jcrs_2011_03_031
crossref_primary_10_1186_s12911_023_02214_3
crossref_primary_10_1007_s10792_012_9537_1
crossref_primary_10_1128_mSphere_00335_17
crossref_primary_10_1007_s10384_010_0838_5
crossref_primary_10_1097_IEB_0b013e3181c70f93
crossref_primary_10_1080_09273948_2023_2170249
crossref_primary_10_3390_jcm10163611
crossref_primary_10_1016_j_jfo_2012_09_010
crossref_primary_10_3341_jkos_2016_57_3_420
crossref_primary_10_1007_s00417_012_2098_1
crossref_primary_10_1007_s00417_010_1501_z
crossref_primary_10_1016_j_jcrs_2008_08_036
crossref_primary_10_1111_iwj_13984
crossref_primary_10_54393_pjhs_v4i08_934
crossref_primary_10_1016_j_jcrs_2007_06_026
crossref_primary_10_1097_j_jcrs_0000000000000018
crossref_primary_10_1038_eye_2013_103
crossref_primary_10_1016_j_ophtha_2015_08_039
crossref_primary_10_1038_eye_2008_208
crossref_primary_10_1111_ceo_13419
crossref_primary_10_1016_j_jcrs_2015_02_026
crossref_primary_10_1097_ICU_0b013e32831b6daf
crossref_primary_10_1016_j_jcrs_2015_02_027
crossref_primary_10_1016_j_jmii_2018_12_011
crossref_primary_10_1016_j_joco_2017_12_004
crossref_primary_10_1007_s00717_016_0306_9
crossref_primary_10_1016_j_jcrs_2015_02_028
crossref_primary_10_1016_j_jfo_2015_05_007
crossref_primary_10_1097_IIO_0000000000000409
crossref_primary_10_1007_s10384_021_00899_5
crossref_primary_10_1016_j_jcrs_2008_08_022
crossref_primary_10_1016_j_ajoint_2024_100034
crossref_primary_10_1136_bjophthalmol_2017_311051
crossref_primary_10_1002_jcph_634
crossref_primary_10_1016_j_jcrs_2013_08_062
crossref_primary_10_1016_j_ophtha_2017_02_019
crossref_primary_10_1016_j_ophtha_2020_06_034
crossref_primary_10_1016_j_jcrs_2016_10_017
crossref_primary_10_1016_j_colsurfb_2017_04_060
crossref_primary_10_1016_S2173_5794_10_70044_X
crossref_primary_10_12968_opti_2017_3_152186
crossref_primary_10_1097_ICU_0000000000000445
crossref_primary_10_1097_ICU_0b013e32834cd5d1
crossref_primary_10_1136_bjophthalmol_2014_306372
crossref_primary_10_1097_ICU_0000000000000326
crossref_primary_10_1111_j_1755_3768_2012_02480_x
crossref_primary_10_1097_j_jcrs_0000000000000245
crossref_primary_10_1016_j_ophtha_2015_08_023
crossref_primary_10_1097_j_jcrs_0000000000000241
crossref_primary_10_1136_bmjophth_2020_000609
crossref_primary_10_1016_j_jconrel_2020_07_020
crossref_primary_10_1097_j_jcrs_0000000000000365
crossref_primary_10_1016_j_jcrs_2007_07_058
crossref_primary_10_1007_s00347_011_2456_0
crossref_primary_10_1016_j_ajoc_2020_100595
crossref_primary_10_1097_ICU_0000000000000329
crossref_primary_10_1007_s00417_016_3473_0
crossref_primary_10_1371_journal_pone_0166141
crossref_primary_10_3390_ph17030321
crossref_primary_10_1007_s00347_008_1829_5
crossref_primary_10_1002_14651858_CD012131_pub2
crossref_primary_10_1016_j_jcrs_2011_04_014
crossref_primary_10_1016_j_preteyeres_2023_101218
crossref_primary_10_2147_OPTH_S292849
crossref_primary_10_1002_14651858_CD012131_pub3
crossref_primary_10_1024_1661_8157_a003900
crossref_primary_10_1159_000350236
crossref_primary_10_1016_j_ajo_2011_01_004
crossref_primary_10_3390_jpm14070695
crossref_primary_10_1016_j_jcrs_2013_08_036
crossref_primary_10_1111_ceo_13444
crossref_primary_10_1155_2012_313248
crossref_primary_10_1097_ICU_0000000000000216
crossref_primary_10_1016_j_jcrs_2010_03_045
crossref_primary_10_1097_ICB_0000000000000884
crossref_primary_10_1155_2011_243170
crossref_primary_10_1016_j_jcrs_2012_11_003
crossref_primary_10_1016_j_jcrs_2007_07_047
crossref_primary_10_1016_j_oftal_2014_06_003
crossref_primary_10_1016_j_jcrs_2014_09_028
crossref_primary_10_1136_bjo_2021_320588
crossref_primary_10_1016_j_ophtha_2016_01_056
crossref_primary_10_1097_IEB_0b013e3181b95da2
crossref_primary_10_1097_APO_0000000000000208
crossref_primary_10_1111_j_1755_3768_2010_01875_x
crossref_primary_10_1586_17469899_3_6_627
crossref_primary_10_1080_09286580802624459
crossref_primary_10_1016_j_ophtha_2019_11_005
crossref_primary_10_1080_17425247_2016_1227785
crossref_primary_10_1017_S095026881400034X
crossref_primary_10_3341_jkos_2019_60_5_480
crossref_primary_10_1089_jop_2020_0034
crossref_primary_10_3109_02713683_2012_746991
crossref_primary_10_1128_CMR_00113_16
crossref_primary_10_2147_OPTH_S247739
crossref_primary_10_1097_j_jcrs_0000000000001231
crossref_primary_10_1007_s00417_016_3287_0
crossref_primary_10_16948_zktipb_855520
crossref_primary_10_1007_s10792_014_0011_0
crossref_primary_10_1002_14651858_CD013270
crossref_primary_10_2165_11537950_000000000_00000
Cites_doi 10.1016/S0886-3350(01)01269-X
10.1016/S0886-3350(02)01483-9
10.1016/j.jcrs.2006.07.009
10.1016/j.jcrs.2004.10.057
10.1001/archopht.123.5.613
10.1136/bjo.87.7.867
10.1016/j.ophtha.2005.02.028
10.1016/j.jcrs.2006.02.014
10.1016/S0161-6420(99)90395-0
10.1053/jhin.2001.1050
10.1136/bjo.82.11.1312
10.1136/bjo.88.1.29
10.1016/j.jcrs.2006.02.021
10.1034/j.1600-0420.2002.800305.x
10.1016/j.jcrs.2006.01.065
10.1016/S0161-6420(91)32312-1
10.1111/j.1600-0420.2005.00377.x
10.1016/S0161-6420(91)32053-0
ContentType Journal Article
Copyright ASCRS and ESCRS
2007 ASCRS and ESCRS
2007 INIST-CNRS
Copyright_xml – notice: ASCRS and ESCRS
– notice: 2007 ASCRS and ESCRS
– notice: 2007 INIST-CNRS
CorporateAuthor Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons
CorporateAuthor_xml – name: Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.jcrs.2007.02.032
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1873-4502
EndPage 988
ExternalDocumentID 10_1016_j_jcrs_2007_02_032
17531690
18837796
S0886335007004609
1_s2_0_S0886335007004609
Genre Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
08R
0R
1-
1B1
1P
1~5
29K
4.4
457
4G.
53G
5GY
5VS
7-5
AAEDT
AAGIX
AAHPQ
AALRI
AAQFI
AAQKA
AAQQT
AAQXK
AAXUO
ABASU
ABDIG
ABFLS
ABIID
ABLJU
ABMAC
ABPTK
ACGFO
ACGFS
ACIUM
ADBBV
ADPAM
AENEX
AEVXI
AFCTW
AFDTB
AFRHN
AFTJW
AGZHU
AITUG
AJIOK
AJUYK
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
ALXNB
AMJPA
AMKUR
AMRAJ
ASPBG
AVWKF
AZFZN
BELOY
C5W
CS3
D-I
DIWNM
DU5
EBS
EJD
F5P
FDB
FEDTE
FGOYB
FO
GBLVA
GJ
GQDEL
HVGLF
HZ
IHE
IKREB
IKYAY
IPNFZ
J1W
K
K-O
KOM
L7B
M41
MO0
NQ-
O9-
OF-
OPF
OQ
OVD
P2P
R2-
RIG
ROL
RPZ
SEL
SES
SJN
SSZ
TEORI
TSPGW
UHS
UV1
XH2
XPP
Z5R
ZA5
ZGI
ZXP
ZZMQN
---
--K
.1-
.FO
.GJ
0R~
1P~
AAEDW
AASCR
ABJNI
ABVCZ
ACILI
ADGGA
ADHPY
ADMUD
AEETU
AHOMT
AINUH
AJNWD
AMNEI
C45
EEVPB
ERAAH
FCALG
GNXGY
HLJTE
HZ~
OQ~
RLZ
IQODW
AAAAV
AAIQE
ACXJB
AHQNM
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AJZMW
CITATION
7X8
ID FETCH-LOGICAL-c549t-73f9d5eef7d7e894d5766ee2c91eb893bc5d9a67b4400383be3a93623c404e723
ISSN 0886-3350
IngestDate Fri Aug 16 01:21:01 EDT 2024
Fri Aug 23 01:00:20 EDT 2024
Thu May 23 23:11:05 EDT 2024
Sun Oct 22 16:06:01 EDT 2023
Fri Feb 23 02:31:18 EST 2024
Thu Aug 18 18:34:55 EDT 2022
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Postoperative
Cataract
Multicenter study
Uvea disease
Identification
Prevention
Eye disease
Lens disease
Treatment
Surgery
Risk factor
Ophthalmology
Endophtalmitis
Anterior segment disease
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c549t-73f9d5eef7d7e894d5766ee2c91eb893bc5d9a67b4400383be3a93623c404e723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-News-2
ObjectType-Feature-3
content type line 23
OpenAccessLink https://doi.org/10.1016/j.jcrs.2007.02.032
PMID 17531690
PQID 70555173
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_70555173
crossref_primary_10_1016_j_jcrs_2007_02_032
pubmed_primary_17531690
pascalfrancis_primary_18837796
elsevier_sciencedirect_doi_10_1016_j_jcrs_2007_02_032
elsevier_clinicalkeyesjournals_1_s2_0_S0886335007004609
PublicationCentury 2000
PublicationDate 2007-06-01
PublicationDateYYYYMMDD 2007-06-01
PublicationDate_xml – month: 06
  year: 2007
  text: 2007-06-01
  day: 01
PublicationDecade 2000
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Journal of cataract and refractive surgery
PublicationTitleAlternate J Cataract Refract Surg
PublicationYear 2007
Publisher Elsevier Inc
Elsevier Science
Publisher_xml – name: Elsevier Inc
– name: Elsevier Science
References Kattan, Flynn, Pflugfelder (bib19) 1991; 98
Barry, Seal, Gettinby (bib2) 2006; 32
Nichamin, Chang, Johnson (bib16) 2006; 32
Seal, Barry, Gettinby (bib1) 2006; 32
Taban, Behrens, Newcomb (bib13) 2005; 123
Allardice, Wright, Peterson, Miller (bib18) 2001; 49
Montan, Wejde, Koranyi, Rylander (bib6) 2002; 28
Schmitz, Dick, Krummenauer, Pfeiffer (bib15) 1999; 106
Bainbridge, Teimory, Tabandeh (bib9) 1998; 82
Montan, Lundström, Stenevi, Thorburn (bib12) 2002; 80
West, Behrens, McDonnell (bib14) 2005; 112
Wallin, Parker, Jin (bib5) 2005; 31
Mayer, Cadman, Ewings (bib17) 2003; 87
Menikoff, Speaker, Marmor, Raskin (bib8) 1991; 98
Wejde, Montan, Lundström (bib7) 2005; 83
Foster (bib21) 2000; 13
Nagaki, Hayasaka, Kadoi (bib10) 2003; 29
(bib3) 2005
Mamalis, Edelhauser, Dawson (bib4) 2006; 32
Taylor (bib22) 2000; 84
Wong, Chee (bib11) 2004; 88
Brian, Taylor (bib20) 2001; 79
18165064 - J Cataract Refract Surg. 2008 Jan;34(1):9-10
Barry (R2-24-20210210) 2006; 32
Wong (R11-24-20210210) 2004; 88
Mayer (R17-24-20210210) 2003; 87
Wallin (R5-24-20210210) 2005; 31
Brian (R20-24-20210210) 2001; 79
Allardice (R18-24-20210210) 2001; 49
Kattan (R19-24-20210210) 1991; 98
Foster (R21-24-20210210) 2000; 13
Wejde (R7-24-20210210) 2005; 83
Taban (R13-24-20210210) 2005; 123
Montan (R12-24-20210210) 2002; 80
West (R14-24-20210210) 2005; 112
Menikoff (R8-24-20210210) 1991; 98
Schmitz (R15-24-20210210) 1999; 106
Mamalis (R4-24-20210210) 2006; 32
Seal (R1-24-20210210) 2006; 32
Bainbridge (R9-24-20210210) 1998; 82
Nagaki (R10-24-20210210) 2003; 29
Montan (R6-24-20210210) 2002; 28
Nichamin (R16-24-20210210) 2006; 32
References_xml – volume: 123
  start-page: 613
  year: 2005
  end-page: 620
  ident: bib13
  article-title: Acute endophthalmitis following cataract surgery; a systematic review of the literature
  publication-title: Arch Ophthalmol
  contributor:
    fullname: Newcomb
– volume: 32
  start-page: 396
  year: 2006
  end-page: 406
  ident: bib1
  article-title: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; case for a European multicenter study; the ESCRS Endophthalmitis Study Group
  publication-title: J Cataract Refract Surg
  contributor:
    fullname: Gettinby
– volume: 84
  start-page: 1
  year: 2000
  end-page: 2
  ident: bib22
  article-title: Cataract: how much surgery do we have to do?
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Taylor
– volume: 112
  start-page: 1388
  year: 2005
  end-page: 1394
  ident: bib14
  article-title: The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001
  publication-title: Ophthalmology
  contributor:
    fullname: McDonnell
– volume: 32
  start-page: 324
  year: 2006
  end-page: 333
  ident: bib4
  article-title: Toxic anterior segment syndrome
  publication-title: J Cataract Refract Surg
  contributor:
    fullname: Dawson
– volume: 49
  start-page: 23
  year: 2001
  end-page: 29
  ident: bib18
  article-title: A statistical approach to an outbreak of endophthalmitis following cataract surgery at a hospital in the West of Scotland
  publication-title: J Hosp Infect
  contributor:
    fullname: Miller
– volume: 80
  start-page: 258
  year: 2002
  end-page: 261
  ident: bib12
  article-title: Endophthalmitis following cataract surgery in Sweden. The 1998 national prospective survey
  publication-title: Acta Ophthalmol Scand
  contributor:
    fullname: Thorburn
– volume: 98
  start-page: 1761
  year: 1991
  end-page: 1768
  ident: bib8
  article-title: A case-control study of risk factors for postoperative endophthalmitis
  publication-title: Ophthalmology
  contributor:
    fullname: Raskin
– volume: 88
  start-page: 29
  year: 2004
  end-page: 31
  ident: bib11
  article-title: Risk factors of acute endophthalmitis after cataract extraction: a case-control study in Asian eyes
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Chee
– volume: 32
  start-page: 1556
  year: 2006
  end-page: 1559
  ident: bib16
  article-title: ASCRS White Paper. What is the association between clear corneal cataract incisions and postoperative endophthalmitis?
  publication-title: J Cataract Refract Surgery
  contributor:
    fullname: Johnson
– volume: 13
  start-page: 17
  year: 2000
  end-page: 19
  ident: bib21
  article-title: Vision 2020: the cataract challenge
  publication-title: Comm Eye Health
  contributor:
    fullname: Foster
– volume: 31
  start-page: 735
  year: 2005
  end-page: 741
  ident: bib5
  article-title: Cohort study of 27 cases of endophthalmitis at a single institution
  publication-title: J Cataract Refract Surg
  contributor:
    fullname: Jin
– volume: 32
  start-page: 407
  year: 2006
  end-page: 410
  ident: bib2
  article-title: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group
  publication-title: J Cataract Refract Surg
  contributor:
    fullname: Gettinby
– volume: 98
  start-page: 227
  year: 1991
  end-page: 238
  ident: bib19
  article-title: Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery
  publication-title: Ophthalmology
  contributor:
    fullname: Pflugfelder
– volume: 83
  start-page: 7
  year: 2005
  end-page: 10
  ident: bib7
  article-title: Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001
  publication-title: Acta Ophthalmol Scand
  contributor:
    fullname: Lundström
– volume: 82
  start-page: 1312
  year: 1998
  end-page: 1315
  ident: bib9
  article-title: Intraocular lens implants and risk of endophthalmitis
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Tabandeh
– volume: 29
  start-page: 20
  year: 2003
  end-page: 26
  ident: bib10
  article-title: Bacterial endophthalmitis after small-incision cataract surgery; effect of incision placement and intraocular lens type
  publication-title: J Cataract Refract Surgery
  contributor:
    fullname: Kadoi
– volume: 87
  start-page: 867
  year: 2003
  end-page: 869
  ident: bib17
  article-title: A 10 year retrospective study of cataract surgery and endophthalmitis in a single eye unit: injectable lenses lower the incidence of endophthalmitis
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Ewings
– volume: 79
  start-page: 249
  year: 2001
  end-page: 256
  ident: bib20
  article-title: Cataract blindness—challenges for the 21st century
  publication-title: Bull World Health Organ
  contributor:
    fullname: Taylor
– volume: 106
  start-page: 1869
  year: 1999
  end-page: 1877
  ident: bib15
  article-title: Endophthalmitis in cataract surgery; results of a German survey
  publication-title: Ophthalmology
  contributor:
    fullname: Pfeiffer
– volume: 28
  start-page: 977
  year: 2002
  end-page: 981
  ident: bib6
  article-title: Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery
  publication-title: J Cataract Refract Surg
  contributor:
    fullname: Rylander
– year: 2005
  ident: bib3
  article-title: ESCRS Guidelines on Prophylaxis, Management and Therapy of Post-Operative Endophthalmitis, Version 1
– volume: 28
  start-page: 977
  year: 2002
  ident: R6-24-20210210
  article-title: Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/S0886-3350(01)01269-X
  contributor:
    fullname: Montan
– volume: 29
  start-page: 20
  year: 2003
  ident: R10-24-20210210
  article-title: Bacterial endophthalmitis after small-incision cataract surgery; effect of incision placement and intraocular lens type.
  publication-title: J Cataract Refract Surgery
  doi: 10.1016/S0886-3350(02)01483-9
  contributor:
    fullname: Nagaki
– volume: 32
  start-page: 1556
  year: 2006
  ident: R16-24-20210210
  article-title: ASCRS White Paper. What is the association between clear corneal cataract incisions and postoperative endophthalmitis?
  publication-title: J Cataract Refract Surgery
  doi: 10.1016/j.jcrs.2006.07.009
  contributor:
    fullname: Nichamin
– volume: 31
  start-page: 735
  year: 2005
  ident: R5-24-20210210
  article-title: Cohort study of 27 cases of endophthalmitis at a single institution.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2004.10.057
  contributor:
    fullname: Wallin
– volume: 79
  start-page: 249
  year: 2001
  ident: R20-24-20210210
  article-title: Cataract blindnesschallenges for the 21st century.
  publication-title: Bull World Health Organ
  contributor:
    fullname: Brian
– volume: 123
  start-page: 613
  year: 2005
  ident: R13-24-20210210
  article-title: Acute endophthalmitis following cataract surgery; a systematic review of the literature.
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.123.5.613
  contributor:
    fullname: Taban
– volume: 87
  start-page: 867
  year: 2003
  ident: R17-24-20210210
  article-title: A 10 year retrospective study of cataract surgery and endophthalmitis in a single eye unit: injectable lenses lower the incidence of endophthalmitis.
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.87.7.867
  contributor:
    fullname: Mayer
– volume: 112
  start-page: 1388
  year: 2005
  ident: R14-24-20210210
  article-title: The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001.
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2005.02.028
  contributor:
    fullname: West
– volume: 13
  start-page: 17
  issue: 34
  year: 2000
  ident: R21-24-20210210
  article-title: Vision 2020: the cataract challenge.
  publication-title: Comm Eye Health
  contributor:
    fullname: Foster
– volume: 32
  start-page: 396
  year: 2006
  ident: R1-24-20210210
  article-title: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; case for a European multicenter study; the ESCRS Endophthalmitis Study Group.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2006.02.014
  contributor:
    fullname: Seal
– volume: 106
  start-page: 1869
  year: 1999
  ident: R15-24-20210210
  article-title: Endophthalmitis in cataract surgery; results of a German survey.
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(99)90395-0
  contributor:
    fullname: Schmitz
– volume: 49
  start-page: 23
  year: 2001
  ident: R18-24-20210210
  article-title: A statistical approach to an outbreak of endophthalmitis following cataract surgery at a hospital in the West of Scotland.
  publication-title: J Hosp Infect
  doi: 10.1053/jhin.2001.1050
  contributor:
    fullname: Allardice
– volume: 82
  start-page: 1312
  year: 1998
  ident: R9-24-20210210
  article-title: Intraocular lens implants and risk of endophthalmitis.
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.82.11.1312
  contributor:
    fullname: Bainbridge
– volume: 88
  start-page: 29
  year: 2004
  ident: R11-24-20210210
  article-title: Risk factors of acute endophthalmitis after cataract extraction: a case-control study in Asian eyes.
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.88.1.29
  contributor:
    fullname: Wong
– volume: 32
  start-page: 407
  year: 2006
  ident: R2-24-20210210
  article-title: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2006.02.021
  contributor:
    fullname: Barry
– volume: 80
  start-page: 258
  year: 2002
  ident: R12-24-20210210
  article-title: Endophthalmitis following cataract surgery in Sweden. The 1998 national prospective survey.
  publication-title: Acta Ophthalmol Scand
  doi: 10.1034/j.1600-0420.2002.800305.x
  contributor:
    fullname: Montan
– volume: 32
  start-page: 324
  year: 2006
  ident: R4-24-20210210
  article-title: Toxic anterior segment syndrome.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2006.01.065
  contributor:
    fullname: Mamalis
– volume: 98
  start-page: 227
  year: 1991
  ident: R19-24-20210210
  article-title: Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery.
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(91)32312-1
  contributor:
    fullname: Kattan
– volume: 83
  start-page: 7
  year: 2005
  ident: R7-24-20210210
  article-title: Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001.
  publication-title: Acta Ophthalmol Scand
  doi: 10.1111/j.1600-0420.2005.00377.x
  contributor:
    fullname: Wejde
– volume: 98
  start-page: 1761
  year: 1991
  ident: R8-24-20210210
  article-title: A case-control study of risk factors for postoperative endophthalmitis.
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(91)32053-0
  contributor:
    fullname: Menikoff
SSID ssj0004235
Score 2.4893832
Snippet Purpose To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery...
To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on...
PURPOSETo identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 978
SubjectTerms Aged
Anterior Chamber - drug effects
Anti-Bacterial Agents - therapeutic use
Antibiotic Prophylaxis
Biological and medical sciences
Cefuroxime - therapeutic use
Endophthalmitis - epidemiology
Endophthalmitis - etiology
Endophthalmitis - prevention & control
Eye Infections, Bacterial - epidemiology
Eye Infections, Bacterial - etiology
Eye Infections, Bacterial - prevention & control
Female
Humans
Incidence
Lens diseases
Lens Implantation, Intraocular
Levofloxacin
Male
Medical sciences
Odds Ratio
Ofloxacin - therapeutic use
Ophthalmology
Phacoemulsification
Postoperative Complications - prevention & control
Prospective Studies
Risk Factors
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the eye and orbit
Title Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0886335007004609
https://dx.doi.org/10.1016/j.jcrs.2007.02.032
https://www.ncbi.nlm.nih.gov/pubmed/17531690
https://search.proquest.com/docview/70555173
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgkxASQtwpl-EH3qpUaWzHCW_TNDQxDaF1E3uzcjkRqrq2alKB-Bn8Ys6xnaQdFAEvUZWb03xf7GP7O58Ze6sziY1uooIoVwl2UJQKEijjAESRVEJHUFjx-NnH-ORSfrhSV70g02aXNPmo-P7bvJL_QRX3Ia6UJfsPyHY3xR34G_HFLSKM27_C-NNqgW9pln1zpiJLMslYgvfyhnmJR5sv2eyafIuGFSK--GpzbLPGujQPa5cTTaMC2Otez5yug0LR48nR-cSpDUm-SZbP1n3aTjWUXmHURZtWn-5X7tkR7XZlWj07VDY5C5-y3kjLbgcfdC-S6uqoOBDCeceOwNWhiRaBVOFWJevcLjyZNmvM1K3g80tN7gYVpqNpsaq902Q0Ct1Y6Aa0y2uLLfmN0oRf36p1WsP20G22H-lUYQd9__D0_PNpnz0buWVY27_iU6ucCvBm8WQy62-4K5K5t8xq_L4qtzDK7p6LjWAuHrD7Hgx-6Hj0kN2C-SN258yLKx6zHxt04ouKb9GJ36AT7-jEW2i5x_Id92SimyCZuCUT3yATt2TiSAW-TSa6gsjEPZmesMv3xxdHJ4FfsiMolEybQIsqLRVApUsNSSpL7M7GAFGRjiHH0DgvVJlmsc6lpDlpkYPIUoyhRCFDCToST9nefDGH54xXstChwhPGpZQihDTBFx-LqIQkynWWDdiwff1m6ZxZTCtZnBrCjZZY1SaMDOI2YLpFyLQ5x9hKQu0_59qMTY1nmgnxgGgQaptYnQ6Y6q70UamLNg1S9Y8lHmwRoX_IJCGXz3jA3rTMMFin00RdNofFujbkcKXGWgzYM0eY_lrPvRc7j7xkd_sP9RXba1ZreI1xc5MfeOL_BAv5yAo
link.rule.ids 315,786,790,27957,27958
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prophylaxis+of+postoperative+endophthalmitis+following+cataract+surgery%3A+results+of+the+ESCRS+multicenter+study+and+identification+of+risk+factors&rft.jtitle=Journal+of+cataract+and+refractive+surgery&rft.date=2007-06-01&rft.issn=0886-3350&rft.eissn=1873-4502&rft.volume=33&rft.issue=6&rft.spage=978&rft_id=info:doi/10.1016%2Fj.jcrs.2007.02.032&rft_id=info%3Apmid%2F17531690&rft.externalDocID=17531690
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08863350%2FS0886335007X01019%2Fcov150h.gif